- 4-Week # shares sold: 2,303
- 12-Week # shares sold: 2,977
- 24-Week # shares sold: 6,877
Here are Wednesday's top research calls, including an upgrade for Clovis Oncology, downgrades for Sketchers USA and Wells Fargo and new coverage for Altria.
Jim Cramer ponders the market's inconsistencies and how some stocks get in trouble.